In DCD liver offers where NRP or hypothermic oxygenated perfusion is available, what donor/recipient factors are still absolute or near-absolute reasons to decline because of ischemic cholangiopathy risk?

Since the advent and subsequent rapid development of machine perfusion techniques, liver transplant programs are ever-broadening their consideration of previously thought to be "extended" donors. Risks of ischemic cholangiopathy may be linked to the expertise of the program in using machine perfusio...